Please provide your email address to receive an email when new articles are posted on . Odds for survival on ECMO to transplant went down if the patient had an older age at listing. Survival did not ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A higher likely risk for mortality in COVID-19 patients ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned ...
Older adults not previously listed for transplant who were bridged to transplant via extracorporeal membrane oxygenation showed favorable survival rates and allograft function up to 5 years later, ...
HONOLULU -- In hindsight, researchers saw more limitations to extracorporeal membrane oxygenation (ECMO) and proning, therapies initially touted as helpful for COVID patients in intensive care.
Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results